Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16158449 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL11891635 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL10065965 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL10065405 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL21129113 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL17102932 | 0.95 | ALDH1A1 (0.44) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL11891632 | 0.95 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL13608535 | 0.93 | ALDH1A1 (0.48) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL14016097 | 0.93 | ALDH1A1 (0.48) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 | |
| SCHEMBL10029836 | 0.92 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP3A4TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2056371-B1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | BANDO CHEMICAL IND (JP) | 2012-09-26 | — | — | EP | disclosed |
| US-8043725-B2 | Organic electroluminescence element | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-10-25 | — | — | US | disclosed |
| US-8043725-B2 | Organic electroluminescence element | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20100006828-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | BANDO CHEMICAL INDUSTRIAL, LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20100006828-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | BANDO CHEMICAL INDUSTRIAL, LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| EP-2056371-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Bando Chemical Industries, Ltd. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20070249866-A1 | METHOD FOR PRODUCING AROMATIC AMINO COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070249861-A1 | METHOD FOR PRODUCING AROMATIC AMINO COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| US-7250532-B2 | Method for producing aromatic amino compound | IDEMITSU KOSAN CO., LTD. (JP) | 2007-07-31 | — | — | US | disclosed |
| US-20060030736-A1 | Method for producing aromatic amino compound | IDEMITSU KOSAN CO., LTD. (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20040082813-A1 | Method for producting aromatic amino compound | IDEMITSU KOSAN CO., LTD. (JP) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249861-A1 | METHOD FOR PRODUCING AROMATIC AMINO COMPOUND | SLC7A1, SLC43A1, AHR | ALDH1A1 455/4885CYP1A2 91/4885CYP3A4 246/4885 |
| US-20060030736-A1 | Method for producing aromatic amino compound | SLC7A1, SLC43A1, AHR | ALDH1A1 447/4885CYP1A2 81/4885CYP3A4 214/4885 |
| US-20040082813-A1 | Method for producting aromatic amino compound | ADRM1, SLC7A1, AHR | ALDH1A1 594/4885CYP1A2 145/4885CYP3A4 269/4885 |
| US-20070249866-A1 | METHOD FOR PRODUCING AROMATIC AMINO COMPOUND | SLC7A1, SLC43A1, AHR | ALDH1A1 455/4885CYP1A2 91/4885CYP3A4 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.